Revvity Revenue 2010-2024 | RVTY

Revvity annual/quarterly revenue history and growth rate from 2010 to 2024. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • Revvity revenue for the quarter ending December 31, 2024 was $0.729B, a 4.81% increase year-over-year.
  • Revvity revenue for the twelve months ending December 31, 2024 was $2.755B, a 0.16% increase year-over-year.
  • Revvity annual revenue for 2024 was $2.755B, a 0.16% increase from 2023.
  • Revvity annual revenue for 2023 was $2.751B, a 16.95% decline from 2022.
  • Revvity annual revenue for 2022 was $3.312B, a 13.48% decline from 2021.
Revvity Annual Revenue
(Millions of US $)
2024 $2,755
2023 $2,751
2022 $3,312
2021 $3,828
2020 $2,663
2019 $2,884
2018 $2,778
2017 $2,257
2016 $2,116
2015 $2,105
2014 $2,070
2013 $2,158
2012 $2,105
2011 $1,919
2010 $1,702
2009 $1,551
Revvity Quarterly Revenue
(Millions of US $)
2024-12-31 $729
2024-09-30 $684
2024-06-30 $692
2024-03-31 $650
2023-12-31 $696
2023-09-30 $671
2023-06-30 $709
2023-03-31 $675
2022-12-31 $741
2022-09-30 $712
2022-06-30 $896
2022-03-31 $963
2021-12-31 $430
2021-09-30 $861
2021-06-30 $1,228
2021-03-31 $1,308
2020-12-31 $235
2020-09-30 $964
2020-06-30 $812
2020-03-31 $652
2019-12-31 $805
2019-09-30 $707
2019-06-30 $723
2019-03-31 $649
2018-12-31 $756
2018-09-30 $674
2018-06-30 $703
2018-03-31 $644
2017-12-31 $642
2017-09-30 $554
2017-06-30 $547
2017-03-31 $514
2016-12-31 $567
2016-09-30 $514
2016-06-30 $536
2016-03-31 $498
2015-12-31 $451
2015-09-30 $563
2015-06-30 $564
2015-03-31 $527
2014-12-31 $441
2014-09-30 $542
2014-06-30 $556
2014-03-31 $531
2013-12-31 $589
2013-09-30 $522
2013-06-30 $541
2013-03-31 $505
2012-12-31 $563
2012-09-30 $510
2012-06-30 $522
2012-03-31 $511
2011-12-31 $539
2011-09-30 $453
2011-06-30 $479
2011-03-31 $447
2010-12-31 $467
2010-09-30 $419
2010-06-30 $422
2010-03-31 $394
2009-12-31 $300
2009-09-30 $377
2009-06-30 $438
2009-03-31 $435
Sector Industry Market Cap Revenue
Medical Medical Services $13.962B $2.755B
Revvity Inc. provides products, services and solutions to the diagnostics, life sciences and applied services markets worldwide. Its operating segment includes Discovery & Analytical Solutions and Diagnostics. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Revvity Inc., formerly known as PerkinElmer Inc., is based in Waltham, Massachusetts.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $150.197B 27.76
Elevance Health (ELV) United States $90.566B 11.84
CVS Health (CVS) United States $82.065B 12.01
Cencora (COR) United States $47.211B 17.13
DiDi Global (DIDIY) China $23.282B 0.00
Natera (NTRA) United States $22.205B 0.00
ICON (ICLR) Ireland $16.651B 14.81
BioMerieux (BMXMF) France $14.074B 0.00
Doximity (DOCS) United States $14.002B 72.82
Viatris (VTRS) United States $13.201B 4.07
Solventum (SOLV) United States $12.870B 0.00
Avantor (AVTR) United States $11.909B 17.49
CochLear (CHEOY) Australia $11.330B 0.00
Medpace Holdings (MEDP) United States $10.506B 27.30
EUROFINS SCIENT (ERFSF) Luxembourg $9.794B 0.00
HealthEquity (HQY) United States $9.682B 48.57
Sonic Healthcare (SKHHY) Australia $8.686B 0.00
Charles River Laboratories (CRL) United States $8.297B 15.72
Amplifon S.p.A (AMFPF) Italy $6.224B 31.72
Bausch + Lomb (BLCO) Canada $5.601B 25.63
Organon (OGN) United States $4.041B 4.12
Sotera Health (SHC) United States $3.829B 20.49
BrightSpring Health Services (BTSG) United States $3.552B 75.56
Surgery Partners (SGRY) United States $3.263B 37.20
Concentras Parent (CON) United States $2.981B 0.00
GeneDx Holdings (WGS) United States $2.791B 338.60
Alignment Healthcare (ALHC) United States $2.755B 0.00
Teladoc Health (TDOC) United States $2.185B 0.00
Ardent Health Partners (ARDT) United States $2.118B 0.00
Progyny (PGNY) United States $2.033B 41.17
PACS (PACS) United States $2.010B 0.00
GoodRx Holdings (GDRX) United States $1.852B 48.60
Premier (PINC) United States $1.726B 11.05
Agilon Health (AGL) United States $1.492B 0.00
Pediatrix Medical (MD) United States $1.480B 12.40
Ryman Healthcare (RYHTY) New Zealand $1.409B 0.00
CareDx (CDNA) United States $1.254B 0.00
AMN Healthcare Services Inc (AMN) United States $0.984B 7.81
Establishment Labs Holdings (ESTA) $0.981B 0.00
Embecta (EMBC) United States $0.838B 5.74
Auna S.A (AUNA) Luxembourg $0.611B 0.00
DocGo (DCGO) United States $0.513B 19.35
SBC Medicals (SBC) United States $0.483B 0.00
Sonida Senior Living (SNDA) United States $0.480B 0.00
MultiPlan (MPLN) United States $0.477B 0.00
InnovAge Holding (INNV) United States $0.453B 0.00
Enhabit (EHAB) United States $0.424B 36.70
Nutex Health (NUTX) United States $0.335B 0.00
LifeMD (LFMD) United States $0.326B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.311B 0.00
QDM (QDMI) Hong Kong, SAR China $0.294B 7.71
Beauty Health (SKIN) United States $0.199B 0.00
Performant Healthcare (PHLT) United States $0.183B 0.00
Sera Prognostics (SERA) United States $0.144B 0.00
Biodesix (BDSX) United States $0.134B 0.00
So-Young (SY) China $0.114B 19.40
IceCure Medical (ICCM) Israel $0.083B 0.00
Ascend Wellness Holdings (AAWH) United States $0.081B 0.00
ModivCare (MODV) United States $0.079B 4.29
Oncology Institute (TOI) United States $0.068B 0.00
NeueHealth (NEUE) United States $0.061B 1.62
Singular Genomics Systems (OMIC) United States $0.051B 0.00
OncoCyte (OCX) United States $0.047B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.035B 0.00
Co-Diagnostics (CODX) United States $0.023B 0.00
Pheton Holdings (PTHL) China $0.019B 0.00
KindlyMD (KDLY) United States $0.018B 0.00
Intelligent Bio Solutions (INBS) United States $0.011B 0.00
SeaStar Medical Holding (ICU) United States $0.008B 0.00
BioNexus Gene Lab (BGLC) $0.006B 0.00
XWELL (XWEL) United States $0.006B 0.00
Aclarion (ACON) United States $0.003B 0.00
ISpecimen (ISPC) United States $0.002B 0.00
NewGenIvf Group (NIVF) Thailand $0.001B 0.00
Cano Health (CANOQ) United States $0.000B 0.00